Darier Disease Latest Advances

Upadacitinib as a Successful Sequential Therapy After Abrocitinib Failure in a Patient With Refractory Darier Disease.

Journal: American journal of therapeutics

Published: June 15, 2026

Linear Darier disease treated with ruxolitinib: Case report and review of the literature.

Journal: JAAD case reports

Published: May 25, 2026

Effect of Anti-IL-23 and Anti-IL-17 Therapy on Darier Disease: A Case Series.

Journal: The Australasian journal of dermatology

Published: March 27, 2026

Distinct Involvement of IL-17A Signaling in Darier Disease and Hailey-Hailey Disease.

Journal: The Journal of dermatology

Published: March 26, 2026

Combined use of isotretinoin and secukinumab in pediatric Darier disease: a sustained clinical response.

Journal: Italian journal of dermatology and venereology

Published: March 16, 2026

Computational dissection of sarco/endoplasmic reticulum Ca²⁺-ATPase 2b C-Terminal extension autoinhibition and its therapeutic potential in Darier's disease.

Journal: Computational biology and chemistry

Published: March 02, 2026

A Case of Darier Disease With p.N767S Mutation in ATP2A2 Successfully Treated With Upadacitinib.

Journal: The American Journal of dermatopathology

Published: February 17, 2026

Oral Magnesium: A Novel Approach in the Management of Hailey-Hailey and Darier Disease.

Journal: Journal of cutaneous medicine and surgery

Published: January 31, 2026

Effective Treatment of Darier Disease With Abrocitinib Combined and Acitretin Capsules: A Case Report.

Journal: American journal of therapeutics

Published: January 08, 2026

Interleukin (IL)-17A Inhibitor as a Treatment for Darier Disease in the Pediatric Population.

Journal: Cureus

Published: January 04, 2026

Transient responses to biologic therapy in Darier disease: consider the role of dysbiosis-driven inflammation.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: December 15, 2025

Expanding the spectrum of Darier Disease variants: 13 novel ATP2A2 genetic variations discovered in an Italian retrospective analysis.

Journal: Gene

Published: December 01, 2025

Darier Disease Latest Advances

Find the Latest Research About Darier Disease

Upadacitinib as a Successful Sequential Therapy After Abrocitinib Failure in a Patient With Refractory Darier Disease.

Upadacitinib as a Successful Sequential Therapy After Abrocitinib Failure in a Patient With Refractory Darier Disease.

Linear Darier disease treated with ruxolitinib: Case report and review of the literature.

Linear Darier disease treated with ruxolitinib: Case report and review of the literature.

Effect of Anti-IL-23 and Anti-IL-17 Therapy on Darier Disease: A Case Series.

Effect of Anti-IL-23 and Anti-IL-17 Therapy on Darier Disease: A Case Series.

Distinct Involvement of IL-17A Signaling in Darier Disease and Hailey-Hailey Disease.

Distinct Involvement of IL-17A Signaling in Darier Disease and Hailey-Hailey Disease.

Combined use of isotretinoin and secukinumab in pediatric Darier disease: a sustained clinical response.

Combined use of isotretinoin and secukinumab in pediatric Darier disease: a sustained clinical response.

Computational dissection of sarco/endoplasmic reticulum Ca²⁺-ATPase 2b C-Terminal extension autoinhibition and its therapeutic potential in Darier's disease.

Computational dissection of sarco/endoplasmic reticulum Ca²⁺-ATPase 2b C-Terminal extension autoinhibition and its therapeutic potential in Darier's disease.

A Case of Darier Disease With p.N767S Mutation in ATP2A2 Successfully Treated With Upadacitinib.

A Case of Darier Disease With p.N767S Mutation in ATP2A2 Successfully Treated With Upadacitinib.

Oral Magnesium: A Novel Approach in the Management of Hailey-Hailey and Darier Disease.

Oral Magnesium: A Novel Approach in the Management of Hailey-Hailey and Darier Disease.

Effective Treatment of Darier Disease With Abrocitinib Combined and Acitretin Capsules: A Case Report.

Effective Treatment of Darier Disease With Abrocitinib Combined and Acitretin Capsules: A Case Report.

Interleukin (IL)-17A Inhibitor as a Treatment for Darier Disease in the Pediatric Population.

Interleukin (IL)-17A Inhibitor as a Treatment for Darier Disease in the Pediatric Population.

Transient responses to biologic therapy in Darier disease: consider the role of dysbiosis-driven inflammation.

Transient responses to biologic therapy in Darier disease: consider the role of dysbiosis-driven inflammation.

Expanding the spectrum of Darier Disease variants: 13 novel ATP2A2 genetic variations discovered in an Italian retrospective analysis.

Expanding the spectrum of Darier Disease variants: 13 novel ATP2A2 genetic variations discovered in an Italian retrospective analysis.